Cartomerge Versus NavX Fusion in Catheter Ablation of Atrial Fibrillation
NCT ID: NCT01432743
Last Updated: 2011-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
101 participants
INTERVENTIONAL
2007-09-30
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Atrial Fibrillation After Catheter Versus Thoracoscopic Ablation Using Patient Activated Implantable Loop Recorders: The ACTUAL Study
NCT01503268
ECG-I Targeted Ablation for Persistent AF Not Responding to Pulmonary Vein Isolation Results of a Two Staged Strategy.
NCT04633265
Catheter Ablation of Atrial Fibrillation Using Hansen Medical Robotic Navigation
NCT01037296
Substrate Remodelling and Targeted Ablation in AF
NCT07047235
Comparison of Rotational Angiography/Electroanatomical Mapping Fusion Versus CT/Electroanatomical Mapping Fusion to Guide AF Ablation
NCT01537237
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cartomerge
Use of Cartomerge to guide ablation
Cartomerge
Guidance of catheter ablation using Cartomerge guidance
NavX Fusion
Use of NavX fusion to guide ablation
NavX Fusion
Using NavX Fusion to guide catheter ablation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NavX Fusion
Using NavX Fusion to guide catheter ablation
Cartomerge
Guidance of catheter ablation using Cartomerge guidance
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be undergoing their first planned procedure for electrophysiology mapping and ablation in the left atrium of AF
* Be willing and able to sign the study specific informed consent
* Have a negative pregnancy test for female subjects of child bearing potential
Exclusion Criteria
* Have any contraindication or allergy to routine procedural medications or catheter materials
* Have any condition for which the investigator feels it is unsafe for the subject to undergo an invasive electrophysiology procedure (EP) catheterisation
* Be currently participating in another clinical research study
* Have any condition for which the subject's life expectancy is less than twelve months
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Barts & The London NHS Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Richard Schilling
Professor of Cardiology and Cardiac Electrophysiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Schilling, FRCP
Role: PRINCIPAL_INVESTIGATOR
Barts and the London NHS Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Barts and the London NHS Trust
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Finlay MC, Hunter RJ, Baker V, Richmond L, Goromonzi F, Thomas G, Rajappan K, Duncan E, Tayebjee M, Dhinoja M, Sporton S, Earley MJ, Schilling RJ. A randomised comparison of Cartomerge vs. NavX fusion in the catheter ablation of atrial fibrillation: the CAVERN Trial. J Interv Card Electrophysiol. 2012 Mar;33(2):161-9. doi: 10.1007/s10840-011-9632-7. Epub 2011 Nov 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
005126
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.